• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CALR 外显子 9 突变检测中的陷阱:571 例阳性患者的单中心经验。

Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patients.

机构信息

Laboratoire de Biologie Cellulaire, AP-HP, Hopital Saint-Louis, Paris, France.

Université de Paris, U1131 INSERM, IRSL, Paris, France.

出版信息

Int J Lab Hematol. 2020 Dec;42(6):827-832. doi: 10.1111/ijlh.13282. Epub 2020 Jul 2.

DOI:10.1111/ijlh.13282
PMID:32614523
Abstract

INTRODUCTION

The pathogenesis of myeloproliferative neoplasms (MPNs) is closely related to the acquisition of specific molecular alterations in JAK2, MPL, or CALR genes, the presence of which represent major diagnostic criteria in the WHO classification. The CALR exon 9 insertions and deletions are very heterogeneous, and their detection mainly relies on polymerase chain reaction (PCR) fragment length analysis.

METHODS

We report on the rare nonclassical profiles that we observed among the 1382 patients analyzed by PCR fragment length analysis. In difficult cases, we tested germline DNA and performed NGS analysis.

RESULTS

We faced some troubling results because of the presence of several unexpected peaks. Our investigations showed that they resulted from a mix of isolated or double somatic mutations combined with germline alterations which could be misleading for a correct diagnosis. The precise interpretation of such difficult cases is mandatory as a misinterpretation could lead to the prescription of cytoreductive drugs to nondiseased persons or to an absence of treatment in true MPN patients.

CONCLUSION

Our observations showed that every mutation should be verified by direct Sanger sequencing, and we show that sometimes it may be necessary to study germline DNA and to complement with NGS analysis to precisely interpret the molecular alterations.

摘要

简介

骨髓增殖性肿瘤(MPNs)的发病机制与 JAK2、MPL 或 CALR 基因获得特定的分子改变密切相关,这些改变的存在是世界卫生组织分类中的主要诊断标准。CALR 外显子 9 的插入和缺失非常多样,其检测主要依赖于聚合酶链反应(PCR)片段长度分析。

方法

我们报告了通过 PCR 片段长度分析分析的 1382 例患者中观察到的罕见非典型谱。在困难的情况下,我们测试了种系 DNA 并进行了 NGS 分析。

结果

由于存在多个意外峰,我们遇到了一些令人困扰的结果。我们的研究表明,这些结果是由孤立或双重体细胞突变与种系改变混合引起的,这可能会对正确诊断造成误导。对这些困难病例进行准确的解释是必要的,因为错误的解释可能导致对无疾病个体开具细胞减少药物或对真正的 MPN 患者缺乏治疗。

结论

我们的观察表明,每个突变都应该通过直接 Sanger 测序进行验证,我们还表明,有时可能需要研究种系 DNA 并通过补充 NGS 分析来精确解释分子改变。

相似文献

1
Pitfalls in CALR exon 9 mutation detection: A single-center experience in 571 positive patients.CALR 外显子 9 突变检测中的陷阱:571 例阳性患者的单中心经验。
Int J Lab Hematol. 2020 Dec;42(6):827-832. doi: 10.1111/ijlh.13282. Epub 2020 Jul 2.
2
Validation of a molecular diagnostic assay for CALR exon 9 indels in myeloproliferative neoplasms: identification of coexisting JAK2 and CALR mutations and a novel 9 bp deletion in CALR.骨髓增殖性肿瘤中CALR外显子9插入缺失的分子诊断检测方法的验证:JAK2和CALR共存突变的鉴定以及CALR中一种新的9bp缺失
Int J Lab Hematol. 2016 Jun;38(3):284-97. doi: 10.1111/ijlh.12484. Epub 2016 Mar 28.
3
Evaluation of methods to detect CALR mutations in myeloproliferative neoplasms.骨髓增殖性肿瘤中检测CALR突变方法的评估
Leuk Res. 2015 Jan;39(1):82-7. doi: 10.1016/j.leukres.2014.11.019. Epub 2014 Nov 29.
4
Development of a Targeted Next-Generation Sequencing Assay to Detect Diagnostically Relevant Mutations of JAK2, CALR, and MPL in Myeloproliferative Neoplasms.一种用于检测骨髓增殖性肿瘤中JAK2、CALR和MPL诊断相关突变的靶向新一代测序检测方法的开发。
Genet Test Mol Biomarkers. 2018 Feb;22(2):98-103. doi: 10.1089/gtmb.2017.0203. Epub 2018 Jan 11.
5
CALR gene mutational profile in myeloproliferative neoplasms with non-mutated JAK2 in Moroccan patients: A case series and germline in-frame deletion.CALR 基因突变谱在摩洛哥患者无突变 JAK2 的骨髓增殖性肿瘤中的研究:病例系列和种系框内缺失。
Curr Res Transl Med. 2017 Jan-Mar;65(1):15-19. doi: 10.1016/j.retram.2016.08.002. Epub 2016 Nov 3.
6
Somatic mutations of calreticulin in myeloproliferative neoplasms.骨髓增殖性肿瘤中钙网蛋白的体细胞突变
Int J Hematol. 2017 Jun;105(6):743-747. doi: 10.1007/s12185-017-2246-9. Epub 2017 May 3.
7
[Allele-specific polymerase chain reaction and electrophoretic detection in the detection algorithm clinically significant somatic mutations in the gene of calreticulin (calr).].[等位基因特异性聚合酶链反应和电泳检测在检测算法中用于检测钙网蛋白(CALR)基因中具有临床意义的体细胞突变。]
Klin Lab Diagn. 2018;63(9):588-592. doi: 10.18821/0869-2084-2018-63-8-588-592.
8
Calreticulin exon 9 mutations in myeloproliferative neoplasms.骨髓增殖性肿瘤中的钙网蛋白外显子9突变
Ann Lab Med. 2015 Jan;35(1):22-7. doi: 10.3343/alm.2015.35.1.22. Epub 2014 Dec 8.
9
The prevalence of CALR mutations in a cohort of patients with myeloproliferative neoplasms.一组骨髓增殖性肿瘤患者中CALR突变的患病率。
Int J Lab Hematol. 2016 Feb;38(1):102-6. doi: 10.1111/ijlh.12447. Epub 2015 Nov 11.
10
CALR, JAK2, and MPL mutation profiles in patients with four different subtypes of myeloproliferative neoplasms: primary myelofibrosis, essential thrombocythemia, polycythemia vera, and myeloproliferative neoplasm, unclassifiable.四种不同亚型骨髓增殖性肿瘤患者(原发性骨髓纤维化、原发性血小板增多症、真性红细胞增多症和无法分类的骨髓增殖性肿瘤)的CALR、JAK2和MPL突变谱
Am J Clin Pathol. 2015 May;143(5):635-44. doi: 10.1309/AJCPUAAC16LIWZMM.

引用本文的文献

1
Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements.骨髓纤维化的分子遗传学特征:对诊断、预后及治疗进展的意义
Cancers (Basel). 2024 Jan 25;16(3):514. doi: 10.3390/cancers16030514.
2
A customized mass array panel for :: tyrosine kinase domain mutation screening in chronic myeloid leukemia.一种用于慢性髓性白血病酪氨酸激酶结构域突变筛查的定制化质谱分析芯片。
J Mass Spectrom Adv Clin Lab. 2023 Apr 13;28:122-132. doi: 10.1016/j.jmsacl.2023.04.002. eCollection 2023 Apr.
3
mutations in myeloproliferative neoplasms: An unfolding story.
骨髓增殖性肿瘤中的突变:一个不断展开的故事。
EXCLI J. 2020 Oct 26;19:1399-1400. doi: 10.17179/excli2020-2985. eCollection 2020.